Institut de la Vision and Essilor


Essilor, world leader in ophthalmic optics, is reinforcing its commitment to visual health with the launch in 2013 of the first preventive lenses offering selective protection against harmful blue light -one of the risk factors in retinal cell degeneration- and against UV rays, which contribute to the development of cataracts.

 Prevention, such as protecting the eye from harmful light, is currently the first line of defence against the worldwide problems of age-related macular degeneration (AMD) and cataracts. These conditions currently affect more than 350 million people around the world, a figure that may double in the next 30 years with the ageing of the population.
This major innovation was made possible thanks to an ambitious four-year research programme conducted in partnership with Paris Vision Institute, one of Europe’s largest eye health integrated research centers, under the leadership of Professor Sahel.

GLOBAL CARE is an outstanding consortium of 5 French expertises :